Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
A Prospective Cohort of Obinutuzumab and Chlorambucil (GC) Chemotherapy for the Treatment of Elderly Patients With Chronic Lymphocytic Leukemia Including Next- Generation Sequencing (NGS)-Based Assess
ClinicalTrials.gov study NCT04059081. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01133743. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The antigen causing IgG hexamerization in patients with Chronic lymphocytic leukemia (CLL) is Alpha 2 macroglobulin (A2M)
Open the record for dataset details and reuse information.
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01868893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
ClinicalTrials.gov study NCT01253460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Subcutaneous Alemtuzumab (CAMPATH®, MabCampath®) in Relapsed/Refractory B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00328198. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00899431. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01649791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lenalidomide as Immune Adjuvant in Patient's With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01924169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Idelalisib in Combination With BI 836826 in Participants With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02538614. IPD Sharing: YES. Countries: 1. Publications: 0.
Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01441882. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab and Ibrutinib for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia, DIRECT Study
ClinicalTrials.gov study NCT04230304. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
ClinicalTrials.gov study NCT01243190. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Using Two Oral Chemotherapy Agents for Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00829647. IPD Sharing: NO. Countries: 0. Publications: 2.
Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00280241. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT06973187. IPD Sharing: YES. Countries: 18. Publications: 0.
A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01077622. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00096044. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients
ClinicalTrials.gov study NCT02481297. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Tenalisib (RP6530) in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT04204057. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.